The UCLA Immunogenetics Center (UIC) provides state-of-the-art Histocompatibility and Immunogenetics testing for solid organ and stem cell transplantation, pre- and post-transplant immune assessment and testing for diagnosis of diseases with associations to the Human Leukocyte Antigens (HLA). As one of the first established laboratories in Histocompatibility and Immunogenetics, we continue to advance the field through research, clinical innovation, proficiency testing and educational training. UIC provides customized testing and support services for clinical trials and clinical research to monitor response to experimental therapy.
The UIC is a nationally recognized reference laboratory for Histocompatibility and Immunogenetics testing and is licensed by the States of California, New York, Maryland, Pennsylvania and Rhode Island, and is CMS certified and accredited by the American Society for Histocompatibility and Immunogenetics (ASHI).
Goals and Mission
- Leading Through Quality: Provide the highest standard of Immunogenetics, Histocompatibility and Transplantation Immunology testing and interpretation to the patients we serve.
- Leading Through Research: Advance the understanding of Immunogenetics and Transplantation Immunology through innovative basic and clinical research.
- Leading Through Development: Be the forefront of development of new technologies and reference materials to improve the quality of patient care.
- Leading Through Training: Training the next generation of leaders in Histocompatibility and Immunogenetics to navigate the complexities of testing and research in Transplantation Immunology.
- Now Recruiting For UCLA Histocompatibility Director Training Program. Applications are being accepted for the Director In Training Position to start July 2017. UCLA Job Posting #JPF02525.
- Awards: Immunogenetics Director In Training Fellow Dr. Nwe New Soe was recognized for her outstanding research at the inaugural UCLA Cardiovascular Theme Symposium. Dr. Soe presented her research on the differential roles of integrin beta-4 cytoplasmic domains on HLA Class I induced endothelial cell migration and proliferation.
- Recruitment: Dr. Monica Cappelletti, PhD was recruited as new assistant professor in the Department of Pathology and Laboratory Medicine and Director of the UCLA Immune Assessment Core.
- Michelle J. Hickey, Ying Zheng, Nicole Valenzuela, Qiuheng Zhang, Carolyn Krystal, Erik Lum, Eileen W. Tsai, Gerald S. Lipshutz, H. Albin Gritsch, Gabriel Danovitch, Jeffrey Veale, David Gjertson, Michael Cecka, Elaine F. Reed. Analysis of the New Kidney Allocation System on UCLA Patients Transplanted from the Deceased Donor Waitlist. Human Immunol. 2016.
- Nicole M Valenzuela, Michelle J Hickey, Elaine F Reed. Antibody Subclass Repertoire and Graft Outcome following Solid Organ Transplantation. Front Immunology. 2016.